INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 435m ago
HOUSE PTR34m ago
SEC 13F34m ago
ROBINHOOD CHAIN34m ago
Corporate insider
LK

Lee Gary K.

Chief Scientific OfficerCIK 0001907345

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 6
Max Insider Score37
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$23K
1,457 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Lyell Immunopharma, Inc.Chief Scientific Officer · Nov 12, 2025
27
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL
$1,879
131 sh
Aug 10, 2026
Aug 11, 2026
traded Aug 10, 2026
+1d
SEC FORM 4

Evidence

37
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$2,460
130 sh
May 11, 2026Jun 15, 2026
traded May 11, 2026
+35dSEC FORM 4

Evidence

31
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$39K
1,671 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC FORM 4

Evidence

27
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$3,399
147 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC FORM 4

Evidence

5
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Grant or award
A—
50.0K sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC FORM 4

Evidence

13
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Grant or award
A—
4,000 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC FORM 4

Evidence

31
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$2,230
138 sh
Nov 10, 2025Nov 12, 2025
traded Nov 10, 2025
+2dSEC FORM 4

Evidence